Furthermore, upon stratification by gender, differential methylation of UBE2I was consistently observed in the PAAD subtype, with high methylation levels in both male and female populations, compared to their control counterparts (P = 0.007, 0.005; Figure 6(e)). Here, UBE2I is linked to pancreatic adenocarcinoma.